Cited by 179Computational Drug Discovery MethodsBioactive natural compoundsSynthesis and Characterization of Heterocyclic Compounds

Multi-Targeted Natural Products Evaluation Based on Biological Activity Prediction with PASS

Lagunin, Alexey, Filimonov, Dmitry, Poroikov, Vladimir·2010·Current Pharmaceutical Design

Abstract

Natural products found a wide use in folk medicine. Presently, when routine development of new drugs faced a considerable challenge, they become an inspiration and valuable source in drugs discovery. Rather complex and diverse chemical structures of natural compounds provide a basis for modulation of different biological targets. Natural compounds exhibit a multitargeted action that may lead to additive/synergistic or antagonistic effects. Rational design of more safe and potent pharmaceuticals requires an estimation of probable multiple actions of natural products. Our software PASS can perform such estimation. It predicts with reasonable accuracy over 3500 pharmacotherapeutic effects, mechanisms of action, interaction with the metabolic system, and specific toxicity for drug-like molecules on the basis of their structural formulae. We analyzed PASS predictions utilizing PharmaExpert, which performs selection of compounds with multiple mechanisms of action, analysis of activity-activity relationships and drug-drug interactions. The paper describes an application of PASS and PharmaExpert to the evaluation of biological activity of natural compounds including marine sponge alkaloids, triterpenoids of lupane group, and their derivatives. Proposed computer-aided methods can generate combinatorial libraries of macrolides. They help to select the most promising pharmaceutical leads with the required properties. Case study, based on the analysis of biological activity spectra predicted for St John's Wort constituents, clearly demonstrates capabilities of computational methods in the evaluation of multitargeted actions, additive/synergistic and/or antagonistic effects of natural products.

Integrity signals

Registry

Crossref · 10.2174/138161210791164063

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • This often generates beneficial therapeutic activities due to additive or synergistic pharmacological effects.

    “This often generates beneficial therapeutic activities,102 due to additive or synergistic pharmacological effects.103”

    From QSAR without borders (2020) · cites this paper as [103]

Cites

Flagged first, then by citations

1 of the 60 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Lagunin, A., Filimonov, D., & Poroikov, V.
Affiliations
Institute of Biomedical Chemistry (RU)
Venue
Current Pharmaceutical Design
Published
2010-05-01
Volume
16
Issue
15
Pages
1703-1717
ISSN
1381-6128 (ISSN-L)
OpenAlex
W2027991790
Cited by
179
References
60
Citations by year
2026: 16 · 2025: 19 · 2024: 11 · 2023: 11 · 2022: 13 · 2021: 11 · 2020: 7 · 2019: 12 · 2018: 9 · 2017: 13 · 2016: 11 · 2015: 13 · 2014: 17 · 2013: 8 · 2012: 3
FWCI
5.26
Type
journal article
Language
en
Open access
closed
Locations
  • Current Pharmaceutical Design (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Physical Sciences › Computer Science › Computational Theory and Mathematics › Computational Drug Discovery Methods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioactive natural compounds
  • Physical Sciences › Chemistry › Organic Chemistry › Synthesis and Characterization of Heterocyclic Compounds
Keywords
PASS software, bioactivity prediction, marine sponge alkaloids, lupane triterpenoids, macrolides, drug-drug interactions, synergistic and antagonistic effects, drug discovery, structure-activity relationship
MeSH terms
Alkaloids, Animals, Biological Products, Drug Interactions, Porifera, Software, Structure-Activity Relationship, Triterpenes, Hypericum, Plant Preparations, Drug Discovery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review